3/9/2023 0 Comments Winnonlin priceWow!Īnother trick: Until recently the single user license was issued for a particular machine. If you have gone over the Tier paid for, Certara would ask for the difference at that time.įor a small CRO (say ≤50 studies/year) that’s an increase in cost of 307%. For cost purposes, multiple trial “options” or “iterations” or “multiple deliverables” against a discrete trial / indication / molecule would still be considered a single “study” or “project”.Ĥ5 days before the end of the contract period, you will be asked to submit a certification document to reconcile the # of actual studies completed to those you purchased. ![]() The premium is based on the number of preclinical or clinical studies the software is used in.Ī Study/Project will be considered a discrete trial for a discrete indication for a discrete molecule. Additionally to the annual single-user license fee (2,444 USD) CROs will be charged a fee based on the number of studies/projects performed per year… Part of the business-lingo I received:Īs services providers use the Phoenix software on behalf of many sponsors and their compounds, they generally receive far greater value from these tools than companies using the software of their own compounds. Certara (the company behind Pharsight) changed their pricing policy for CROs (only!).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |